Data search
Results for MligTC455_26219
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_26219 | 33 | 0.69 | Mlig455_032559 | Neo: Irradiation Age: Down-Up-Down |
Mlig455_032559 {REF} {Length: 2476} {TRANSSPLICED} {RNA1509_38431} {RNA1310_17856.1} {RNA815_9396} |
Cumulative graph for MligTC455_26219
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_26219
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_26219 | 33 | 0.69 | Mlig455_032559 | Neo: Irradiation Age: Down-Up-Down |
1 | - | - | - | - | 1.000 | - | Mlig455_032559 {REF} {Length: 2476} {TRANSSPLICED} {RNA1509_38431} {RNA1310_17856.1} {RNA815_9396} | |
| 2. | MligTC455_43753 | 82 | 1.71 | Mlig455_018087 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_018087 {REF} {Length: 2050} {RNA1509_20267} {RNA1310_4680} {RNA815_3273} | |
| 3. | MligTC455_20099 | 15 | 0.32 | Mlig455_037109 | Neo: - Age: - |
0.984 | - | - | - | - | 0.984 | - | Mlig455_037109 {REF} {Length: 817} {NoTransDecoderORF} {RNA1310_30726} {RNA815_35778} | |
| 4. | MligTC455_10605 | 2 | 0.04 | Mlig455_047968 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886} | |
| 5. | MligTC455_19126 | 10 | 0.2 | Mlig455_009225 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743} | |
| 6. | MligTC455_55494 | 2 | 0.05 | Mlig455_004790 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_004790 {REF} {Length: 600} {Pfam: Receptor family ligand binding region [PF01094.30, score=64.3]; Periplasmic binding protein [PF13458.8, score=19.1]} | |
| 7. | MligTC455_33875 | 32 | 0.67 | Mlig455_039631 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738} | |
| 8. | MligTC455_00622 | 2 | 0.05 | Mlig455_047108 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_047108 {REF} {Length: 64} {NoTransDecoderORF} | |
| 9. | MligTC455_07618 | 9 | 0.19 | Mlig455_046329 | Neo: - Age: - |
UNK | 0.967 | - | - | - | - | 0.967 | - | Mlig455_046329 {REF} {Length: 3693} {Pfam: Unkempt Zinc finger domain 1 (Znf1) [PF18384.3, score=68.1]; Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=24.9]} {Human: ENSG00000132478, UNK, unkempt family zinc finger, [RH, Score=435, Expect=3e-140]} {Mouse: ENSMUSG00000020770, Unk, unkempt family zinc finger, [RH, Score=435, Expect=2e-140]} {Dmel: FBgn0004395, unk, unkempt, [RH, Score=414, Expect=6e-134]} {Celegans: WBGene00016407, C34D10.2, [RH, Score=418, Expect=9e-136]} {Smed: dd_Smed_v6_3128_1_1, dd_Smed_v6_3128_1_1, [RH, Score=483, Expect=7e-160]} {RNA1509_7679} {RNA1310_1262.1} {RNA815_11537} |
| 10. | MligTC455_25445 | 12 | 0.24 | Mlig455_021534 | Neo: - Age: Up-Down-Up |
CACNA1D | 0.966 | - | - | - | - | 0.966 | - | Mlig455_021534 {REF} {Length: 4880} {Pfam: Ion transport protein [PF00520.33, score=359.2]; Voltage gated calcium channel IQ domain [PF08763.13, score=102.5]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.9]} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=971, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=957, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=971, Expect=0.0]; ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=959, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=958, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=989, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=1053, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_17, dd_Smed_v6_8899_0_17, [Score=1104, Expect=0.0]} {RNA1509_48072} {RNA1310_376.1} {RNA815_1126.1} |
| 11. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.963 | - | - | - | - | 0.963 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
| 12. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
| 13. | MligTC455_37761 | 12 | 0.26 | Mlig455_014845 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_014845 {REF} {Length: 2142} {Pfam: CUB domain [PF00431.22, score=21.3]} {RNA1310_77188} | |
| 14. | MligTC455_37789 | 16 | 0.34 | Mlig455_002723 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_002723 {REF} {Length: 349} {NoTransDecoderORF} {RNA1310_134759} | |
| 15. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
| 16. | MligTC455_18779 | 25 | 0.52 | Mlig455_005598, Mlig455_014462 | Neo: Int S/G2/M Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_005598 {REF} {Length: 2962} {Pfam: Ubiquitin carboxyl-terminal hydrolase [PF13423.8, score=32.9]; Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=28.1]} {RNA1509_51598} {RNA1310_23460} {RNA815_38515} Mlig455_014462 {REF} {Length: 286} {NoTransDecoderORF} {RNA1310_100624} |